XML 70 R56.htm IDEA: XBRL DOCUMENT v3.23.3
Stockholders’ Equity (Details) - Schedule of Compensation Expense Related to our Stock-Based Awards - USD ($)
$ in Thousands
3 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Schedule of Total Operating Expenses in the Consolidated Statements of Operations [Abstract]    
Research and Development $ 533 $ 1,168
General and Administrative 1,288 1,181
Cost of revenue 62
Total $ 1,883 $ 2,349